Nu Skin (NUS) Q2 FY26 earnings call

Nu Skin's second quarter saw continued progress in the global rollout of its Prysm iO intelligent anti-aging platform, with significant increases in device placements and scans, though initial usage patterns differed from expectations. The company maintained a focus on profitability, achieving adjusted EPS near guidance, but faced headwinds from foreign currency and non-cash impairment charges. Strategic priorities include refining the sales force compensation, optimizing the operating model, and delaying the India market launch to ensure long-term success.